BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24337067)

  • 1. miRNA-302b suppresses human hepatocellular carcinoma by targeting AKT2.
    Wang L; Yao J; Zhang X; Guo B; Le X; Cubberly M; Li Z; Nan K; Song T; Huang C
    Mol Cancer Res; 2014 Feb; 12(2):190-202. PubMed ID: 24337067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-302b suppresses cell invasion and metastasis by directly targeting AKT2 in human hepatocellular carcinoma cells.
    Wang L; Yao J; Sun H; Sun R; Chang S; Yang Y; Song T; Huang C
    Tumour Biol; 2016 Jan; 37(1):847-55. PubMed ID: 26254095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-302b suppresses cell proliferation by targeting EGFR in human hepatocellular carcinoma SMMC-7721 cells.
    Wang L; Yao J; Shi X; Hu L; Li Z; Song T; Huang C
    BMC Cancer; 2013 Oct; 13():448. PubMed ID: 24083596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-302b-3p Suppresses Cell Proliferation Through AKT Pathway by Targeting IGF-1R in Human Gastric Cancer.
    Guo B; Zhao Z; Wang Z; Li Q; Wang X; Wang W; Song T; Huang C
    Cell Physiol Biochem; 2017; 42(4):1701-1711. PubMed ID: 28743112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
    Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
    Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cell proliferation and metastasis of human hepatocellular carcinoma by miR-137 is regulated by CDC42.
    Gao M; Liu L; Li S; Zhang X; Chang Z; Zhang M
    Oncol Rep; 2015 Nov; 34(5):2523-32. PubMed ID: 26352279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q
    Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of miR-302b-5p expression and molecular mechanism in hepatocellular carcinoma: Findings based on RT-qPCR and in silico analysis.
    Wu HY; Cai KT; Ma J; Chen G; Dang YW; Lu HP; Pan SL
    Pathol Res Pract; 2019 Jul; 215(7):152424. PubMed ID: 31103408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FoxD3-regulated microRNA-137 suppresses tumour growth and metastasis in human hepatocellular carcinoma by targeting AKT2.
    Liu LL; Lu SX; Li M; Li LZ; Fu J; Hu W; Yang YZ; Luo RZ; Zhang CZ; Yun JP
    Oncotarget; 2014 Jul; 5(13):5113-24. PubMed ID: 24970808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-582-5p inhibits proliferation of hepatocellular carcinoma by targeting CDK1 and AKT3.
    Zhang Y; Huang W; Ran Y; Xiong Y; Zhong Z; Fan X; Wang Z; Ye Q
    Tumour Biol; 2015 Nov; 36(11):8309-16. PubMed ID: 26002580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-449a suppresses hepatocellular carcinoma cell growth via G1 phase arrest and the HGF/MET c-Met pathway.
    Cheng J; Wu LM; Deng XS; Wu J; Lv Z; Zhao HF; Yang Z; Ni Y
    Hepatobiliary Pancreat Dis Int; 2018 Aug; 17(4):336-344. PubMed ID: 30108016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-637 suppresses melanoma progression through directly targeting P-REX2a and inhibiting PTEN/AKT signaling pathway.
    Zhang J; Liu WL; Zhang L; Ge R; He F; Gao TY; Tian Q; Mu X; Chen LH; Chen W; Li X
    Cell Mol Biol (Noisy-le-grand); 2018 Aug; 64(11):50-57. PubMed ID: 30213289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-3127 promotes cell proliferation and tumorigenicity in hepatocellular carcinoma by disrupting of PI3K/AKT negative regulation.
    Jiang J; Zhang Y; Guo Y; Yu C; Chen M; Li Z; Tian S; Sun C
    Oncotarget; 2015 Mar; 6(8):6359-72. PubMed ID: 25849943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
    Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
    Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.
    Yu M; Xue H; Wang Y; Shen Q; Jiang Q; Zhang X; Li K; Jia M; Jia J; Xu J; Tian Y
    Int J Oncol; 2017 Mar; 50(3):975-983. PubMed ID: 28098858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.
    Xu Q; Liu X; Liu Z; Zhou Z; Wang Y; Tu J; Li L; Bao H; Yang L; Tu K
    Mol Cancer; 2017 Jun; 16(1):103. PubMed ID: 28606154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
    Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
    Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway.
    Xie Y; Du J; Liu Z; Zhang D; Yao X; Yang Y
    J Exp Clin Cancer Res; 2019 Jan; 38(1):7. PubMed ID: 30621734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
    Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
    Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.